China Pharma Holdings Inc. stock is traded at $0.5181, with a volume of 44,400. It is down -7.47% in the last 24 hours and down -31.05% over the past month. China Pharma Holdings, Inc. develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People's Republic of China. The company offers products in the form of dry powder injectables, liquid injectables, tablets, capsules, cephalosporin oral solutions, and granules. The company's products include Cerebroprotein Hydroloysate injection to treat memory decline and attention deficit; Gastrodin injection for tiredness, loss of concentration, poor sleep, and traumatic syndromes of the brain; Propylgallate and Ozagrel Sodium to treat cerebral thrombosis, coronary heart disease, and after surgery complications; Alginic Sodium Diester injection for ischemic heart, cerebrovascular, and high lipoprotein blood diseases; Bumetanide to treat edema diseases; and Candesartan for hypertension. It also provides Roxithromycin dispersible tablets for pharyngitis and tonsillitis; Cefaclor dispersible tablets for tympanitis, lower respiratory tract infection, urinary tract infections, and skin/skin tissue infection; Cefalexin capsules for acute tonsillitis; Anhydroandrographolide for ischemic heart, cerebrovascular, and high lipoprotein blood diseases; Clarithromycin granules and capsules; and Naproxen Sodium and PseudophedrineHydrochlorida sustained release tablets. In addition, the company offers Hepatocyte growth-promoting factor, Tiopronin, Compound Ammonium Glycyrrhetate S, and Omeparzole for the treatment of digestive diseases. Further, it provides Vitamin B6 injection; and Granisetron Hydrochloride injection to treat nausea and vomiting caused by radiotherapy and chemotherapy during the treatment of malignant tumors. The company offers its products through distributors, as well as through its network of 16 sales offices and approximately 1,000 sales representatives. China Pharma Holdings, Inc. is headquartered in Haikou, the People's Republic of China.
Previous Close:
$0.5599
Open:
$0.5599
24h Volume:
44,400
Relative Volume:
0.58
Market Cap:
$22.29M
Revenue:
$3.99M
Net Income/Loss:
-$3.55M
P/E Ratio:
-
EPS:
-$0.5509
Net Cash Flow:
$94,500
1W Performance:
-9.09%
1M Performance:
-31.05%
6M Performance:
-48.00%
1Y Performance:
-65.91%
1-Day Range:
$0.4987$0.5599
1-Week Range:
$0.4987$0.5986
52-Week Range:
$0.3818$19.19
China Pharma Holdings Inc. Stock (CPHI) Company Profile
Name
China Pharma Holdings Inc.Sector
HealthcarePhone
86 898 6681 1730Address
No. 17, Jinpan Road, Second Floor, Haikou, ChinaMarket Cap
Revenue
Net Income
Cash Flow
EPS